The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome.
OBJECTIVE
It is unclear whether treatment of patients with Budd-Chiari syndrome (BCS) should be based on liver histology, as large histopathological studies have not been performed. We investigated the relationship between the histopathological findings and survival.


METHODS
We studied the clinical features and findings on biopsy specimens in 45 patients with BCS who were admitted to four tertiary referral medical centers. Histological findings, i.e. congestion, necrosis, inflammation and fibrosis, were graded. Survival was assessed in relation to histological findings and clinical features at the time of diagnosis as well as in relation to subsequent treatment with or without portosystemic shunting.


RESULTS
Centrilobular congestion, centrilobular necrosis, lobular inflammation and portal inflammation were not significantly related to survival. In addition, there was no association between either pericentral or periportal fibrosis and survival. Univariate analysis revealed that the prothrombin time and Child-Pugh score were significantly related to survival (P = 0.005 and Ptrend = 0.02, respectively). Multivariate analysis yielded the Child-Pugh score, serum alanine aminotransferase (ALT) and treatment with portosystemic shunting as independent prognostic indicators.


CONCLUSIONS
We found no evidence for a relationship between early liver pathology and survival. Child-Pugh score, serum ALT and portosystemic shunting appeared to be prognostic indicators for patients with BCS.
Tang
T J
TJ
Department of Gastroenterology and Hepatology, University Hospital Rotterdam, The Netherlands.
Batts
K P
KP
de Groen
P C
PC
van Hoek
B
B
Haagsma
E B
EB
Hop
W C
WC
Janssen
H L
HL
D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D006502:Budd-Chiari Syndrome / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D005260:Female; D006801:Humans; D008099:Liver / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011170:Portasystemic Shunt, Surgical; D011379:Prognosis; D015996:Survival Rate